Internal Medicine, Pulmonary Disease · Sylacauga, AL
NPI
1932218286
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
315 W Fort Williams St Ste 200
Sylacauga, AL, 35150
Phone (256) 401-0390
Groups this clinician bills Medicare through
Medicare paid, 2024
$150K
3,948 services
Medicare patients, 2024
478
Average age 74
Drug cost, 2024
$3.8M
3,069 prescriptions
Company payments, 2025
$15K
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Emily K Rehberg was code 94375 (pulmonary function testing), 980 times for 459 patients. In total Emily K Rehberg billed 3,948 services in 23 codes, and Medicare paid $150K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-06-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 94375 Pulmonary Function Testing | Office | 980 | 459 | $24.17 | $24K |
| 94726 Pulmonary Function Testing | Office | 776 | 447 | $33.94 | $26K |
| 94729 Pulmonary Function Testing | Office | 776 | 447 | $33.71 | $26K |
| 99214 Office E&M - Established | Office | 390 | 273 | $80.71 | $31K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 312 | 34 | $0.21 | $66.69 |
| 96372 Injection Administration | Office | 178 | 78 | $8.66 | $1,542 |
| 99215 Office E&M - Established | Office | 121 | 102 | $120.72 | $15K |
| 94618 Pulmonary Function Testing | Office | 105 | 95 | $22.13 | $2,323 |
| 99213 Office E&M - Established | Office | 99 | 88 | $52.93 | $5,240 |
| 99205 Office E&M - New | Office | 92 | 92 | $140.99 | $13K |
| J2920 Injection, methylprednisolone sodium succinate, up to 40 mg | Office | 37 | 35 | $2.53 | $93.67 |
| 87428 Infectious Agent Detection by DNA/RNA | Office | 19 | 19 | $63.70 | $1,210 |
| 99223 Hospital E&M - Initial | Facility | 14 | 14 | $120.58 | $1,688 |
| 99204 Office E&M - New | Office | 14 | 14 | $114.61 | $1,604 |
By year: 2022 $186K for 4,129 services; 2023 $178K for 4,033 services; 2024 $150K for 3,948 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87428 Infectious Agent Detection by DNA/RNA | 19 | 19 | $63.70 | $1,210 |
Medicare prescription drug claims, 2024
In 2024, the drug Emily K Rehberg prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 587 prescriptions and refills. In total Emily K Rehberg wrote 3,069 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 587 | 831 | 233 | $530K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 327 | 377 | 191 | $7,839 |
| Breo Ellipta Fluticasone/Vilanterol | 308 | 428 | 116 | $168K |
| Montelukast Sodium Generic | 294 | 733 | 155 | $4,410 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 100 | 148 | 48 | $92K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 92 | 140 | 37 | $63K |
| Fasenra Benralizumab | 84 | 150 | 23 | $499K |
| Spiriva Respimat Tiotropium Bromide | 80 | 133 | 37 | $68K |
| Prolastin C Alpha-1-Proteinase Inhibitor | 65 | 65 | Under 11 | $627K |
| Pantoprazole Sodium Generic | 54 | 139 | 27 | $675 |
| Omeprazole Generic | 50 | 119 | 27 | $856 |
| Azithromycin Generic | 48 | 85 | 27 | $588 |
| Fluticasone Propionate Generic | 48 | 86 | 25 | $786 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 44 | 80 | 26 | $37K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 43 | 59 | 19 | $7,587 |
Brand drugs: 2,010 claims; generic drugs: 1,059 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Emily K Rehberg $15K ($15K in general payments such as food, travel and fees) from 19 companies. The largest payer was GlaxoSmithKline, LLC. with $13K.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 60 | $13K |
| AstraZeneca Pharmaceuticals LP AZN | 18 | $624 |
| Insmed, Inc. INSM | 9 | $227 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 9 | $222 |
| Regeneron Healthcare Solutions, Inc. REGN | 10 | $194 |
| Amgen Inc. AMGN | 10 | $165 |
| Genzyme Corporation SNY | 9 | $163 |
| Grifols USA, LLC | 7 | $147 |
| Intuitive Surgical, Inc. ISRG | 1 | $93.13 |
| Verona Pharma, Inc. VRNA | 3 | $75.01 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.